Arbutus Biopharma Logo
Arbutus to Present at Jefferies Healthcare Conference
31 mai 2023 07h30 HE | Arbutus Biopharma Corporation
WARMINSTER, Pa., May 31, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
LOGO ND NW.png
UPDATE -- Nano Dimension’s Conference Call: Special Tender Offer to Increase Ownership in Stratasys
30 mai 2023 09h04 HE | Nano Dimension Ltd.
Investors’ Call on Tuesday, May 30th, 2023 at 9:00 a.m. EDT The Company Will Address the Merits of the $18.00 Offer That Delivers Certain All-Cash Value At a Premium The Company Will Also...
LOGO ND NW.png
Nano Dimension’s Conference Call: Special Tender Offer to Increase Ownership in Stratasys
30 mai 2023 08h00 HE | Nano Dimension Ltd.
Investors’ Call on Tuesday, May 30th, 2023 at 9:00 a.m. EDT The Company Will Address the Merits of the $18.00 Offer That Delivers Certain All-Cash Value At a Premium The Company Will Also...
Mettler-Toledo International Inc. Announces Webcast of Presentation at the Jefferies Healthcare Conference
25 mai 2023 17h15 HE | Mettler-Toledo, LLC
Columbus, OH, May 25, 2023 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Jefferies Healthcare Conference on Thursday, June...
AssemblyBio_logo_RGB.png
Assembly Biosciences to Present During the 2023 Jefferies Healthcare Conference
23 mai 2023 16h05 HE | Assembly Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral...
HillmanLogo__Black.png
Hillman Announces Participation at Upcoming Investor Conferences During June 2023
23 mai 2023 07h30 HE | The Hillman Group
CINCINNATI, May 23, 2023 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, today announced...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
11 mai 2023 16h05 HE | Cyclacel
- Key Catalysts ahead with multiple Value Generating Readouts -- Expects to Report Phase 1/2 Data Releases with Oral Fadraciclib -- Advancing single-agent Efficacy with Differentiated Oral Plogosertib...
Cavco_Logo.png
Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2023 Fourth Quarter and Year End Earnings Release and Conference Call Webcast
11 mai 2023 16h05 HE | Cavco Industries, Inc.
PHOENIX, May 11, 2023 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the fourth quarter and fiscal year ended April 1, 2023 on Thursday, May 18, 2023 after the...
BWEN Logo.png
Broadwind Announces First Quarter 2023 Results
11 mai 2023 07h00 HE | Broadwind
CICERO, Ill., May 11, 2023 (GLOBE NEWSWIRE) -- Broadwind, Inc. (Nasdaq: BWEN, “Broadwind” or the “Company”), a diversified precision manufacturer of specialized components and solutions serving...
FINAL_VeruIncLogo_RGB_300dpi.jpg
Veru Reports Fiscal 2023 Second Quarter Financial Results
11 mai 2023 06h30 HE | Veru Inc.
Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of hospitalized COVID-19 adult patients at high risk for acute respiratory distress syndrome (ARDS),...